China News Service, Shijiazhuang, January 15 (Huang Xinyao) On the evening of the 15th, Shijiazhuang held the 11th press conference on the prevention and control of the new crown pneumonia epidemic.
Wang Shengchi, chairman of the Critical Care Professional Committee of the Shijiazhuang Medical Association, said that at present, national critical medical experts and provincial critical medical experts have begun to guide the diagnosis and treatment of patients with new coronary pneumonia. Five people have come to Shijiazhuang.
Wang Shengchi said that the ICU is composed of provincial-level critical medicine experts and hospital experts composed of two directors responsible for the system; critically ill/critically ill patients one person and one team; Chinese medicine diagnosis and treatment one person and one dose; medical staff keep close monitoring for 24 hours, and report any changes in the condition.
On the same day, Wang Shengchi popularized some professional knowledge about new coronary pneumonia to the public, such as the determination of suspected cases and confirmed cases, and the classification of clinically confirmed cases.
Wang Shengchi said that the new type of coronavirus pneumonia is a new acute respiratory infectious disease, which belongs to a category B infectious disease and is managed as a category A infectious disease.
At present, it has become a major global public health event.
Spread through respiratory droplets and close contact is the main route of transmission.
Contact with virus-contaminated items can also cause infection.
The crowd is generally susceptible.
A certain degree of immunity can be obtained after infection or vaccination with the new coronavirus, but the duration is not clear.
He said that the general treatment principles for patients with new coronary pneumonia are: early psychological intervention, strengthening the monitoring of vital signs, encouraging patients to exercise moderately, strengthening nutrition, strengthening the management of oxygen therapy, strengthening the management of patients' daily intake and output, and strengthening Chinese medicine treatment.
(Finish)